This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Sep;138(9):2068-2072.

doi: 10.1016/j.jid.2018.03.1496. Epub 2018 Mar 17.

Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors

Megan H Noe¹, Arash Mostaghimi², Misha Rosenbach³, Kanade Shinkai⁴, Robert G Micheletti⁵

Affiliations

Affiliations

¹ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
² Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
⁴ Department of Dermatology University of California-San Francisco, San Francisco, California, USA.
⁵ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: robert.micheletti@uphs.upenn.edu.

PMID: 29559345
DOI: 10.1016/j.jid.2018.03.1496

Free article

Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors

Megan H Noe et al. J Invest Dermatol. 2018 Sep.

Free article

. 2018 Sep;138(9):2068-2072.

doi: 10.1016/j.jid.2018.03.1496. Epub 2018 Mar 17.

Authors

Megan H Noe¹, Arash Mostaghimi², Misha Rosenbach³, Kanade Shinkai⁴, Robert G Micheletti⁵

Affiliations

¹ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
² Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
⁴ Department of Dermatology University of California-San Francisco, San Francisco, California, USA.
⁵ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: robert.micheletti@uphs.upenn.edu.

PMID: 29559345
DOI: 10.1016/j.jid.2018.03.1496

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
- scite Smart Citations